UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057691
Receipt number R000065887
Scientific Title A Clinical trial on the Effects of test substance GL-2 on Posture and Fatigue : single blinded study
Date of disclosure of the study information 2025/04/23
Last modified on 2025/04/21 16:57:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Clinical trial on the Effects of test substance GL-2 on Posture and Fatigue

Acronym

A Clinical trial on the Effects of test substance GL-2 on Posture and Fatigue

Scientific Title

A Clinical trial on the Effects of test substance GL-2 on Posture and Fatigue : single blinded study

Scientific Title:Acronym

A Clinical trial on the Effects of test substance GL-2 on Posture and Fatigue

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of test substance GL-2 on posture and fatigue

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Quantification of standing posture after 2 weeks(image analysis)

Key secondary outcomes

Subjective evaluation after 2 weeks (fatigue)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

2-week intervention of test substance GL-2

Interventions/Control_2

non-intervention(2-week)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1.Healthy males and females aged 20 to 69 years-old.
2.Those who frequently feel foot fatigue or have flat feet
3.Subjects who stand or walk while wearing shoes for more than 5 hours per day, at least 5 days a week.
4.Subjects who walk more than 5,000 steps per day
5.Subjects who can make self-judgment and are voluntarily giving written informed consent.

Key exclusion criteria

Subjects (who)
1. are/might be pregnant or lactating during the current study periods.
2. spend less than 5 hours per day wearing shoes (Subjects who switch to sandals or other types of non-shoe footwear during the day).
3. do not experience fatigue in their legs in daily life.
4. are currently undergoing outpatient treatment for disorders of the foot or leg, or who have previously undergone foot surgery.
5. legs are affected by severe pain or disability.
6. are prohibited from engaging in physical activity by their physician.
7. have severe cardiac, respiratory, circulatory disorders, or other serious disease.
8. ability to exercise is restricted due to injuries or disabilities of the lower extremities.
9. are using specific medications that affect symptoms of the lower extremities.
10. have a smoking habit.
11. can't stop drinking from 2 days before each measurement.
12. have excessive alcohol intake more than 20 g/day of pure alcohol equivalent for more than 4 days a week.
13. are under treatment for or have a history of drug addiction and/or alcoholism.
14. have participated in other clinical studies within one month prior to obtaining informed consent, or plan to participate in other studies.
15. are judged as unsuitable for the current study by the investigator for other reasons.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Kaneko

Organization

Japan Clinical Trial Association

Division name

N.A.

Zip code

1600022

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

TEL

0364574666

Email

info@yakujihou.org


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Kaneko

Organization

Japan Clinical Trial Association

Division name

N.A.

Zip code

1600022

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

TEL

0364574666

Homepage URL


Email

info@yakujihou.org


Sponsor or person

Institute

Japan Clinical Trial Association

Institute

Department

Personal name



Funding Source

Organization

TOYO SHINYAKU Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Pharmaceutical Law Wisdoms

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

Tel

0364574911

Email

master@yakujihou.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 03 Month 19 Day

Date of IRB


Anticipated trial start date

2025 Year 04 Month 24 Day

Last follow-up date

2025 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 23 Day

Last modified on

2025 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065887